Sector: MedicalCOMBINATORX (NASDAQ: CRXX)
Headlines
- Emerging Stock Report Initiates Independent Research Coverage on CombinatoRx, Incorporated
Jan 13, 2010 12:02 PM | CRXX
- CombinatoRx Oncology Programs Demonstrate Synergistic Anti-Cancer Activity in Multiple Myeloma and Other B-Cell Malignancies
Dec 08, 2009 07:30 AM | CRXX
- CombinatoRx Oncology Programs to Be Highlighted at ASH 2009
Nov 24, 2009 07:30 AM | CRXX
- BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen
Nov 20, 2009 03:08 PM | CRL, CRXX, DNDN, POZN
- FDA Extends NDA Review for Exalgo(TM) Extended-Release Tablets
Nov 20, 2009 07:30 AM | CRXX
- BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
Nov 16, 2009 11:56 AM | ALKS, CRL, CRXX, CYTX, HGSI, HHS
- CombinatoRx'S Synavive (CRx-102) Maintains Efficacy Throughout 12 Month Phase 2 Knee OA Extension Trial
Oct 21, 2009 07:30 AM | CRXX
- CombinatoRx Abstract Accepted for Oral Presentation at ACR 2009
Oct 08, 2009 07:30 AM | CRXX
- Levi & Korsinsky LLP Investigates Possible Breach of Fiduciary Duty by Board of CombinatoRx, Inc. - CRXX
Sep 30, 2009 02:25 PM | CRXX
- Swine Flu Stocks Moving Markets at Mid Week
Sep 24, 2009 01:16 AM | CRXX, CVM, XOMA
- CombinatoRx Announces Senior Management Team Changes
Jan 06, 2010 09:55 AM | CRXX
- CombinatoRx and Neuromed Close Merger
Dec 21, 2009 04:53 PM | CRXX
- Stockholders of CombinatoRx and Neuromed Vote for Merger
Dec 18, 2009 01:51 PM | CRXX
- FDA Extends NDA Review for Exalgo Extended-Release Tablets
Nov 20, 2009 07:54 AM | CRXX
- Neuromed Receives FDA Feedback on New Drug Application for Exalgo Extended-Release Tablets
Nov 16, 2009 07:52 AM | CRXX
- CombinatoRx Reports Financial Results for the Third Quarter 2009
Nov 03, 2009 07:52 AM | CRXX
- CombinatoRx-Derived Combination Drug Candidate, Prednisporin, Acquired By Sanofi-Aventis Through Proposed Acquisition of Fovea Pharmaceuticals
Oct 05, 2009 07:53 AM | CRXX
- CombinatoRx Reports Financial Results for the Second Quarter 2009
Aug 10, 2009 07:50 AM | CRXX
- CombinatoRx to Webcast Conference Call Discussing Second Quarter 2009 Financial Results
Jul 31, 2009 08:01 AM | CRXX
- CombinatoRx Publishes Research Demonstrating Improved Selectivity Through Synergistic Combinations
Jul 06, 2009 08:05 AM | CRXX
- Form 4 COMBINATORX, INC For: Jan 26 Filed by: Cole Jason (10K)
Jan 28, 2010 09:16 AM
- Form 4 COMBINATORX, INC For: Jan 15 Filed by: Wright C. Eugene (10K)
Jan 20, 2010 02:14 PM
- Form 4 COMBINATORX, INC For: Jan 15 Filed by: Snutch Terrance P. (10K)
Jan 20, 2010 02:14 PM
- Form 4 COMBINATORX, INC For: Jan 15 Filed by: Richardson Hartley T (10K)
Jan 20, 2010 02:13 PM
- Form 4 COMBINATORX, INC For: Jan 15 Filed by: Renz Justin A (10K)
Jan 20, 2010 02:12 PM
- Form 4 COMBINATORX, INC For: Jan 15 Filed by: OSHEA WILLIAM J (10K)
Jan 20, 2010 02:12 PM
- Form 4 COMBINATORX, INC For: Jan 15 Filed by: Kauffman Michael (10K)
Jan 20, 2010 02:12 PM
- Form 4 COMBINATORX, INC For: Jan 15 Filed by: Hunter William L (10K)
Jan 20, 2010 02:09 PM
- Form 4 COMBINATORX, INC For: Jan 15 Filed by: HAYDU FRANK (10K)
Jan 20, 2010 02:09 PM
- Form 4 COMBINATORX, INC For: Jan 15 Filed by: Gallen Christopher C. (10K)
Jan 20, 2010 02:08 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CRXX
|
Compare to S&P
|
| YTD |
51.81 %
|
58.77 %
|
| 4 Weeks |
61.37 %
|
73.30 %
|
| 12 Weeks |
-22.70 %
|
-20.72 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 15.79 %
|
|
EPS Growth in Last Year: 64.44 %
|
|
Sales Growth in Last Quarter: -17.36 %
|
|
Sales Growth in Last Quarter: -21.23 %
|
|
